Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
5
result was found. Results that relate to
Drug administration
Study on the management strategy of anticancer drugs in pharmacy intravenous admixture services based on failure mode and effect analysis
Published on
Frontiers in Pharmaceutical Sciences
2024,27(5):841-847.
9892 times
1894 times
YANG Dianli
LI Jing
YU Yajing
Failure mode
Effect analysis
Pharmacy intravenous admixture services
Antitumor drug
Drug administration
Details
Signal mining of adverse drug reaction related to MET-TKIs after marketing based on FAERS database
Published on
Frontiers in Pharmaceutical Sciences
2025,29(2):300-310.
11097 times
1659 times
WANG Meisa
HAN Qiushuang
GAO Liang
JIANG Yuan
CHEN Zhe
Mesenchymal-epithelial transition factor tyrosine kinase inhibitors
Food and
Drug Administration
Adverse Event Reporting System
Adverse event signal mining
Disproportionality analysis
Pharmacovigilance
Details
Signal mining of vericiguat-related adverse events and characteristic analysis of elderly patients based on FAERS database
Published on
Frontiers in Pharmaceutical Sciences
2025,29(2):311-317.
10696 times
1485 times
HU Jie
JIANG Qiu
MAO Kaili
ZHONG Songyang
SUN Huayu
Vericiguat
Adverse events
Pharmacovigilance
Food and
Drug Administration
Adverse Event Reporting System
Details
Artificial intelligence reshapes hospital pharmacy practice: advances in application and real-world challenges
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2080-2087.
6761 times
1081 times
FANG Haiyan
HE Qing
Artificial intelligence
Hospital pharmacy
Machine learning
Natural language processing
Deep learning
Big data
Rational use of drug
Drug administration
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):885-894.
1591 times
559 times
ZHANG Hua
LI Pengfei
FU Hongjun
U.S. Food and
Drug Administration
European Medicines Agency
Ar-tificial intelligence
Drug development
Guide principles
Regulatory science
Details